MIDAMOR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Midamor, and when can generic versions of Midamor launch?
Midamor is a drug marketed by Padagis Us and is included in one NDA.
The generic ingredient in MIDAMOR is amiloride hydrochloride. There are five drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the amiloride hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Midamor
A generic version of MIDAMOR was approved as amiloride hydrochloride by ENDO OPERATIONS on January 22nd, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MIDAMOR?
- What are the global sales for MIDAMOR?
- What is Average Wholesale Price for MIDAMOR?
Summary for MIDAMOR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 63 |
| Clinical Trials: | 5 |
| Patent Applications: | 4,439 |
| DailyMed Link: | MIDAMOR at DailyMed |
Recent Clinical Trials for MIDAMOR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Venkata Yellepeddi | Early Phase 1 |
| University of Utah | Early Phase 1 |
| Center for Addiction and Mental Health | Early Phase 1 |
US Patents and Regulatory Information for MIDAMOR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Padagis Us | MIDAMOR | amiloride hydrochloride | TABLET;ORAL | 018200-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
